Finance

Lists
Q3 2026 earnings • released • EPS beat +35.00% • Revenue beat +4.07%
See results
AFX:ETR
Carl Zeiss Meditec AG
€29.90
+2.05%
(+0.60) 1D
Aug 7, 5:35:06 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for AFX...
Open
€29.00
High
€30.20
Low
€28.98
Mkt. cap
2.60B
Avg. vol.
297.56K
Volume
380.89K
Dividend
1.84%
Quarterly dividend
€0.14
Ex-dividend date
Mar 27, 2026
P/E ratio
27.83
52-wk high
€48.36
52-wk low
€22.62
EPS
€1.07
Shares outstanding
89.44M
No. of employees
6K
Open
€29.00
High
€30.20
Low
€28.98
Mkt. cap
2.60B
Avg. vol.
297.56K
Volume
380.89K
Dividend
1.84%
Quarterly dividend
€0.14
Ex-dividend date
Mar 27, 2026
P/E ratio
27.83
52-wk high
€48.36
52-wk low
€22.62
EPS
€1.07
Shares outstanding
89.44M
No. of employees
6K
News stories
From sources across the web
Profile
Carl Zeiss Meditec AG is a multinational medical technology company. Headquartered in Jena, Germany, the company operates as part of the larger Carl Zeiss Group. Doing business as ZEISS Medical Technology, the company develops and manufactures solutions for ophthalmology, dentistry, oncology, neurosurgery, microsurgery, and other medical applications. Wikipedia
About Carl Zeiss Meditec AG
CEOMarkus Weber
Employees5.8K
Founded2002
HeadquartersJena, Thuringia, Germany
SectorMedical device
Websitezeiss.com
Last report
Aug 6, 2026
Fiscal period
Q3 2026
EPS / Est. (EUR)
€0.54 / €0.40
+35.00%beat
Revenue / Est. (EUR)
562.72M / 540.72M
+4.07%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
627.54M
467.00M
524.00M
562.72M
Cost of goods sold
295.75M
239.80M
260.62M
260.44M
Cost of revenue
295.75M
239.80M
260.62M
260.44M
Research and development expenses
91.78M
75.50M
89.30M
78.94M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
169.64M
152.00M
150.59M
162.39M
Operating expense
261.40M
227.50M
237.90M
240.02M
Total operating expenses
557.15M
467.30M
498.52M
500.46M
Operating income
70.40M
-300.00K
25.48M
62.26M
Other non operating income
-4.02M
-200.00K
4.27M
7.88M
EBT including unusual items
67.29M
-5.50M
25.79M
69.16M
EBT excluding unusual items
62.61M
-5.50M
25.79M
69.16M
Income tax expense
13.05M
200.00K
6.76M
16.40M
Effective tax rate
19.39%
-3.64%
26.21%
23.71%
Other operating expenses
-17.00K
-
-1.99M
-1.31M
Net income
51.81M
-4.90M
19.57M
55.03M
Net profit margin
8.26%
-1.05%
3.73%
9.78%
Earnings per share
-
0.03
0.45
0.54
Interest and investment income
570.00K
1.20M
1.28M
2.09M
Interest expense
-6.30M
-6.00M
-6.16M
-5.93M
Net interest expenses
-5.73M
-4.80M
-4.88M
-3.84M
Depreciation and amortization charges
-
-
-
-
EBITDA
83.01M
12.31M
63.70M
74.87M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps